Globex Laboratories (R&D) Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 04-07-2024
- Paid Up Capital ₹ 9.61 Cr
as on 04-07-2024
- Company Age 26 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 Cr
as on 04-07-2024
- Satisfied Charges ₹ 31.90 Cr
as on 04-07-2024
- Revenue 76.72%
(FY 2022)
- Profit 155.31%
(FY 2022)
- Ebitda 67.23%
(FY 2022)
- Net Worth 17.22%
(FY 2022)
- Total Assets 18.58%
(FY 2022)
About Globex Laboratories (R&D)
The Corporate was formerly known as Globex Laboratories (R&D) Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 9.61 Cr.
The company currently has active open charges totaling ₹8.00 Cr. The company has closed loans amounting to ₹31.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Harish Goswamy, Neerav Goswamy, and Shakun Goswamy serve as directors at the Company.
- CIN/LLPIN
U24150MH1998PLC115539
- Company No.
115539
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Jun 1998
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Globex Laboratories (R&D)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shakun Goswamy  | Managing Director | 29-Jun-1998 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harish Goswamy | Director | 29-Jun-1998 | Current |
| Neerav Goswamy | Director | 29-Jun-1998 | Current |
Financial Performance and Corporate Structure Insights of Globex Laboratories (R&D).
Globex Laboratories (R&D) Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 76.72% increase. The company also saw a substantial improvement in profitability, with a 155.31% increase in profit. The company's net worth Soared by an impressive increase of 17.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Globex Laboratories (R&D)?
In 2023, Globex Laboratories (R&D) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rex-Tone Industries LimitedActive 30 years 7 monthsHarish Goswamy, Neerav Goswamy and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Dec 2020 | ₹8.00 Cr | Open |
Others Creation Date: 24 Dec 2020 | ₹5.00 M | Satisfied |
Others Creation Date: 06 Oct 2015 | ₹9.00 Cr | Satisfied |
How Many Employees Work at Globex Laboratories (R&D)?
Globex Laboratories (R&D) has a workforce of 29 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Globex Laboratories (R&D), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Globex Laboratories (R&D)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
